692 related articles for article (PubMed ID: 25531348)
21. Gut microbiota in the pathogenesis of inflammatory bowel disease.
Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
[TBL] [Abstract][Full Text] [Related]
22. Modulating Composition and Metabolic Activity of the Gut Microbiota in IBD Patients.
Matijašić M; Meštrović T; Perić M; Čipčić Paljetak H; Panek M; Vranešić Bender D; Ljubas Kelečić D; Krznarić Ž; Verbanac D
Int J Mol Sci; 2016 Apr; 17(4):. PubMed ID: 27104515
[TBL] [Abstract][Full Text] [Related]
23. The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy.
Cammarota G; Ianiro G; Cianci R; Bibbò S; Gasbarrini A; Currò D
Pharmacol Ther; 2015 May; 149():191-212. PubMed ID: 25561343
[TBL] [Abstract][Full Text] [Related]
24. Practical Considerations and the Intestinal Microbiome in Disease: Antibiotics for IBD Therapy.
Fedorak RN; Ismond KP
Dig Dis; 2016; 34(1-2):112-21. PubMed ID: 26982586
[TBL] [Abstract][Full Text] [Related]
25. The microbiome and inflammatory bowel disease: is there a therapeutic role for fecal microbiota transplantation?
Damman CJ; Miller SI; Surawicz CM; Zisman TL
Am J Gastroenterol; 2012 Oct; 107(10):1452-9. PubMed ID: 23034604
[TBL] [Abstract][Full Text] [Related]
26. The gut microbiota in inflammatory bowel disease.
Macfarlane GT; Blackett KL; Nakayama T; Steed H; Macfarlane S
Curr Pharm Des; 2009; 15(13):1528-36. PubMed ID: 19442170
[TBL] [Abstract][Full Text] [Related]
27. Review of Saccharomyces boulardii as a treatment option in IBD.
Sivananthan K; Petersen AM
Immunopharmacol Immunotoxicol; 2018 Dec; 40(6):465-475. PubMed ID: 29771163
[TBL] [Abstract][Full Text] [Related]
28. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
[TBL] [Abstract][Full Text] [Related]
29. Characterisation and therapeutic manipulation of the gut microbiome in inflammatory bowel disease.
Schulberg J; De Cruz P
Intern Med J; 2016 Mar; 46(3):266-73. PubMed ID: 26968595
[TBL] [Abstract][Full Text] [Related]
30. Probiotics, prebiotics and antibiotics in inflammatory bowel disease.
Cummings JH; Kong SC
Novartis Found Symp; 2004; 263():99-111; discussion 111-4, 211-8. PubMed ID: 15669637
[TBL] [Abstract][Full Text] [Related]
31. Antibiotics and probiotics in inflammatory bowel disease: why, when, and how.
Prantera C; Scribano ML
Curr Opin Gastroenterol; 2009 Jul; 25(4):329-33. PubMed ID: 19444096
[TBL] [Abstract][Full Text] [Related]
32. Bacteriotherapy for inflammatory bowel disease: therapeutic tool and/or pharmacological vectors?
Marteau P; Sokol H; Dray X; Seksik P
Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S228-34. PubMed ID: 20117346
[TBL] [Abstract][Full Text] [Related]
33. Probiotics in Inflammatory Bowel Disease.
Abraham BP; Quigley EMM
Gastroenterol Clin North Am; 2017 Dec; 46(4):769-782. PubMed ID: 29173520
[TBL] [Abstract][Full Text] [Related]
34. Contentious host-microbiota relationship in inflammatory bowel disease--can foes become friends again?
Satokari R
Scand J Gastroenterol; 2015 Jan; 50(1):34-42. PubMed ID: 25523554
[TBL] [Abstract][Full Text] [Related]
35. The microbiome in inflammatory bowel disease and its modulation as a therapeutic manoeuvre.
Hart AL; Hendy P
Proc Nutr Soc; 2014 Nov; 73(4):452-6. PubMed ID: 25221893
[TBL] [Abstract][Full Text] [Related]
36. Role of Probiotics in Crohn's Disease and in Pouchitis.
Guslandi M
J Clin Gastroenterol; 2015; 49 Suppl 1():S46-9. PubMed ID: 26447964
[TBL] [Abstract][Full Text] [Related]
37. Prebiotics and Probiotics in Inflammatory Bowel Disease: Where are we now and where are we going?
Naseer M; Poola S; Ali S; Samiullah S; Tahan V
Curr Clin Pharmacol; 2020; 15(3):216-233. PubMed ID: 32164516
[TBL] [Abstract][Full Text] [Related]
38. The role of antibiotic and probiotic therapies in current and future management of inflammatory bowel disease.
Ewaschuk JB; Tejpar QZ; Soo I; Madsen K; Fedorak RN
Curr Gastroenterol Rep; 2006 Dec; 8(6):486-98. PubMed ID: 17105688
[TBL] [Abstract][Full Text] [Related]
39. Systematic review with meta-analysis: the efficacy of probiotics in inflammatory bowel disease.
Derwa Y; Gracie DJ; Hamlin PJ; Ford AC
Aliment Pharmacol Ther; 2017 Aug; 46(4):389-400. PubMed ID: 28653751
[TBL] [Abstract][Full Text] [Related]
40. Classical and recent advances in the treatment of inflammatory bowel diseases.
Sales-Campos H; Basso PJ; Alves VB; Fonseca MT; Bonfá G; Nardini V; Cardoso CR
Braz J Med Biol Res; 2015 Feb; 48(2):96-107. PubMed ID: 25466162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
